Jefferies Financial Group’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-454,508
Closed -$9.92M 1733
2025
Q4
$9.92M Buy
+454,508
New +$9.44M 0.05% 318
2024
Q4
Sell
-65,000
Closed -$2.45M 1584
2024
Q3
$2.45M Sell
65,000
-35,000
-35% -$1.35M 0.02% 529
2024
Q2
$3.96M Buy
100,000
+86,259
+628% +$2.79M 0.04% 354
2024
Q1
$462K Buy
+13,741
New +$462K ﹤0.01% 1085
2023
Q4
Sell
-164,265
Closed -$5.15M 1686
2023
Q3
$5.15M Buy
164,265
+49,276
+43% +$1.55M 0.05% 330
2023
Q2
$3.64M Buy
+114,989
New +$3.72M 0.03% 449

Other funds holding ATEX

Jefferies Financial Group's ATEX Position: Q1 2026 in Review

Jefferies Financial Group sold out of Anterix (ATEX) in Q1 2026, closing a stake of 454,508 shares — an estimated $9.92M sold.

Jefferies Financial Group first reported a position in ATEX in Q2 2023 and held it in 6 quarters. The position peaked at $9.92M in Q4 2025. 132 funds tracked by Wall St. Rank hold ATEX as of Q1 2026.

  • Jefferies Financial Group reported no remaining Anterix position as of Q1 2026 after selling out during the quarter.
  • Jefferies Financial Group sold 454,508 Anterix shares in Q1 2026, an estimated $9.92M.
  • Jefferies Financial Group first reported a position in Anterix in Q2 2023 and held it in 6 quarters.
  • Jefferies Financial Group's Anterix position peaked at $9.92M in Q4 2025.
  • 132 funds tracked by Wall St. Rank held Anterix as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.